- 67.24+0.71 (+1.07%)At close:4:00 PM EDTMon. Mar 20, 202367.14 -0.10 (-0.15%)Pre mkt:4:57 AM EDTTue. Mar 21, 2023Nasdaq Real Time Price (USD) · Pre-Market TimeAdd to watchlist
Morningstar Published February 02 · Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A... Read more
- Mkt Cap141.12BP/E (TTM)22.79Div & Yield2.28 & 3.39%
- Prev. Close66.5352 Wk. Low65.2852 Wk. High81.44
Bristol-Myers Squibb Co (BMY) Stock Price & News - Google Finance Home BMY • NYSE Bristol-Myers Squibb Co Follow Share $67.30 Mar 20, 3:58:36 PM GMT-4 · USD · NYSE · Disclaimer search Compare...
Bristol Myers Squibb stock (NYSE: BMY), which currently trades at $75 per share, looks like it has only a little room for growth. By Trefis Team Contributor Apr 28, 2022
Bristol-Myers Squibb trades on the New York Stock Exchange (NYSE) under the ticker symbol \\"BMY.\\" Bristol-Myers Squibb saw a increase in short interest in April. As of April 15th, there was short interest totalling 77,458,472 shares, an increase of 61.2% from the March 29th total of 48,063,938 shares. Based on an average daily volume of 18,421,723...
Bristol-Myers Squibb Co (NYSE:BMY) posted its earnings results on Thursday, April, 25th. The biopharmaceutical company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.09 by $0.01. The biopharmaceutical company earned $5.92 billion during the quarter, compared to analysts' expectations of $5.72 billion. Bristol-Myers Squibb ...
Bristol-Myers Squibb is scheduled to release their next quarterly earnings announcement on Thursday, July 25th 2019. View Earnings Estimates for Bristol-Myers Squibb.
Bristol-Myers Squibb updated its FY19 earnings guidance on Thursday, April, 25th. The company provided earnings per share guidance of $4.10-4.20 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.18. Bristol-Myers Squibb also updated its FY 2019 guidance to $4.10-4.20 EPS.
16 Wall Street analysts have issued \\"buy,\\" \\"hold,\\" and \\"sell\\" ratings for Bristol-Myers Squibb in the last year. There are currently 9 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of \\"Hold.\\" View Analyst Ratings for Bristol-Myers Squibb.
Press coverage about BMY stock has been trending somewhat positive this week, InfoTrie Sentiment reports. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Bristol-Mye...
Bristol-Myers Squibb has a market capitalization of $76.89 billion and generates $22.56 billion in revenue each year. The biopharmaceutical company earns $4.92 billion in net income (profit) each year or $3.98 on an earnings per share basis. Bristol-Myers Squibb employs 23,300 workers across the globe.
Bristol-Myers Squibb's mailing address is 430 E. 29TH STREET 14 FLOOR, NEW YORK NY, 10016. The biopharmaceutical company can be reached via phone at 212-546-4000 or via email at email@example.com.
- (844) 978-6257
People also ask
What is the upside for Bristol-Myers Squibb (BMS) stock?
How much is a share of BMY stock?
What was the 52 Week high for Bristol-Myers Squibb stock?
Mar 17, 2023 · The 33 analysts offering price forecasts for Bristol-Myers Squibb have a median target of 73.91, with a high estimate of 95.00 and a low estimate of 58.00. The median estimate represents a 90.02...
Nov 8, 2016 · Bemis Company stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here .